Healthcare & Life Sciences
Capsida Bio
United Statescapsida.com
Capsida Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
2019
Founded
1
Investors
About Capsida Bio
Capsida Bio is a company founded in 2019 headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Capsida Bio engineers novel adeno-associated viruses (AAVs) and develops targeted gene therapies for neurological and ocular diseases using advanced capsid engineering and preclinical screening technologies.
Explore Capsida Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.